Personalis, Inc. (PSNL) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the Personale's second quarter 2024 earnings conference call. All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note that this event is being recorded. I would now like to turn the call over to Caroline Corner, Investor Relations. Please go ahead. Thank you, Operator. Welcome to PersonAlyssa's second quarter 2024 earnings call. Joining today's call are Chris Hall, Chief Executive Officer and President, Erin Toshibana, Chief Financial and Chief Operating Officer, and Rich Chen, Chief Medical Officer and EVP R&D. All statements made on this call do not relate to matters of historical fact, should be considered forward-looking statements within the meaning of U.S. securities laws. For example, any statements regarding trends and expectations for our financial performance this year and longer term, cash runway, revenue expectations and timing, reimbursement goals, size and booking of orders, products, services, technology, clinical milestones, the outcome and timing of reimbursement decisions, expectations for existing and future collaboration activities, cost expectations, our market opportunity, and business outlook. These statements are subject to risks and uncertainties that could cause actual results to differ materially from our current expectations. We encourage you to review our most recent filings with SEC including the risk factors described in our most recent filings. Personnelist undertakes no obligation to update these statements, except as required by applicable law. Our press release with our second quarter 2024 results is available on our website, www.personnelist.com, under the Investors section, and includes additional details about our financial result...